Add Papers Marked0
Paper checked off!

Marked works

Viewed0

Viewed works

Shopping Cart0
Paper added to shopping cart!

Shopping Cart

Register Now

internet library
Atlants.lv library
FAQ
3,99 € Add to cart
Add to Wish List
Want cheaper?
ID number:415142
Evaluation:
Published: 13.03.2020.
Language: English
Level: College/University
Literature: 9 units
References: Not used
Extract

Conclusion
1.No nanomedicine that combines two or more drugs in a single platform has been approved for clinical use yet. Some of the designs of the nanoplatforms used for these combinations are fairly complex thereby limiting excitement in the context of successful clinical development. Most of the designs and synthesis procedure outlined provide little to no ratiometric control of the two or more drugs that are trapped inside these nanoparticles. Clearly, more optimization is needed for such nano-combinations to find maximal therapeutic responses.
2.Next generation of nano-combinations need to be easy to manufacture and provide excellent control on drug ratios with exceptional batch-to-batch reproducibility. Another factor rarely considered is, if some of these nanoplatforms are successful in getting clinical.

Load more similar papers

Atlants

Choose Authorization Method

Email & Password

Email & Password

Wrong e-mail adress or password!
Log In

Forgot your password?

Draugiem.pase
Facebook
Twitter

Not registered yet?

Register and redeem free papers!

To receive free papers from Atlants.com it is necessary to register. It's quick and will only take a few seconds.

If you have already registered, simply to access the free content.

Cancel Register